AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
Characterization of adjacent breast tumors using oligonucleotide microarrays
Authors: Unger, MA Rishi, M Clemmer, VB Hartman, JL Keiper, EA Greshock, JD Chodosh, LA Liebman, MN Weber, BL
Citation: Ma. Unger et al., Characterization of adjacent breast tumors using oligonucleotide microarrays, BREAST CA R, 3(5), 2001, pp. 336-NIL_2
Breast cancer genetics: what we know and what we need (vol 7, pg 552, 2001)
Authors: Nathanson, KL Wooster, R Weber, BL
Citation: Kl. Nathanson et al., Breast cancer genetics: what we know and what we need (vol 7, pg 552, 2001), NAT MED, 7(6), 2001, pp. 749-749
Breast cancer genetics: What we know and what we need
Authors: Nathanson, KN Wooster, R Weber, BL
Citation: Kn. Nathanson et al., Breast cancer genetics: What we know and what we need, NAT MED, 7(5), 2001, pp. 552-556
Recent advances in breast cancer biology
Authors: Gerrero, MR Weber, BL
Citation: Mr. Gerrero et Bl. Weber, Recent advances in breast cancer biology, CURR OPIN O, 13(6), 2001, pp. 415-419
'Other' breast cancer susceptibility genes: searching for more holy grail
Authors: Nathanson, KL Weber, BL
Citation: Kl. Nathanson et Bl. Weber, 'Other' breast cancer susceptibility genes: searching for more holy grail, HUM MOL GEN, 10(7), 2001, pp. 715-720
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic
Authors: Martin, AM Blackwood, MA Antin-Ozerkis, D Shih, HA Calzone, K Colligon, TA Seal, S Collins, N Stratton, MR Weber, BL Nathanson, KL
Citation: Am. Martin et al., Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic, J CL ONCOL, 19(8), 2001, pp. 2247-2253
Breast cancer screening for high-risk women: Too little, too late?
Authors: Armstrong, K Weber, BL
Citation: K. Armstrong et Bl. Weber, Breast cancer screening for high-risk women: Too little, too late?, J CL ONCOL, 19(4), 2001, pp. 919-920
Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations - Facts and controversy
Authors: Eisen, A Weber, BL
Citation: A. Eisen et Bl. Weber, Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations - Facts and controversy, N ENG J MED, 345(3), 2001, pp. 207-208
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
Authors: Rebbeck, TR Wang, YT Kantoff, PW Krithivas, K Neuhausen, SL Godwin, AK Daly, MB Narod, SA Brunet, JS Vesprini, D Garber, JE Lynch, HT Weber, BL Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, CANCER RES, 61(14), 2001, pp. 5420-5424
Genetic and hormonal risk factors in breast cancer
Authors: Martin, AM Weber, BL
Citation: Am. Martin et Bl. Weber, Genetic and hormonal risk factors in breast cancer, J NAT CANC, 92(14), 2000, pp. 1126-1135
Kinetics of BRCA1 regulation in response to UVC radiation
Authors: Clarkin, CEK Zhang, H Weber, BL
Citation: Cek. Clarkin et al., Kinetics of BRCA1 regulation in response to UVC radiation, CELL MOL L, 57(7), 2000, pp. 1126-1134
BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers
Authors: Shih, HA Nathanson, KL Seal, S Collins, N Stratton, MR Rebbeck, TR Weber, BL
Citation: Ha. Shih et al., BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers, CLIN CANC R, 6(11), 2000, pp. 4259-4264
An Alu-mediated 7.1 kb deletion of BRCAI exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10
Authors: Rohlfs, EM Puget, N Graham, ML Weber, BL Garber, JE Skrzynia, C Halperin, JL Lenoir, GM Silverman, LM Mazoyer, S
Citation: Em. Rohlfs et al., An Alu-mediated 7.1 kb deletion of BRCAI exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10, GENE CHROM, 28(3), 2000, pp. 300-307
NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCTdomain
Authors: Ozaki, T Nagase, T Ichimiya, S Seki, N Ohiri, M Nomura, N Takada, N Sakiyama, S Weber, BL Nakagawara, A
Citation: T. Ozaki et al., NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCTdomain, DNA CELL B, 19(8), 2000, pp. 475-485
Recent advances in breast cancer biology
Authors: Unger, MA Weber, BL
Citation: Ma. Unger et Bl. Weber, Recent advances in breast cancer biology, CURR OPIN O, 12(6), 2000, pp. 521-525
Low penetrance genes associated with increased risk for breast cancer
Authors: Weber, BL Nathanson, KL
Citation: Bl. Weber et Kl. Nathanson, Low penetrance genes associated with increased risk for breast cancer, EUR J CANC, 36(10), 2000, pp. 1193-1199
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer
Authors: Eisen, A Rebbeck, TR Wood, WC Weber, BL
Citation: A. Eisen et al., Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer, J CL ONCOL, 18(9), 2000, pp. 1980-1995
Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations
Authors: Pierce, LJ Strawderman, M Narod, SA Oliviotto, I Eisen, A Dawson, L Gaffney, D Solin, LJ Nixon, A Garber, J Berg, C Isaacs, C Heimann, R Olopade, OI Haffty, B Weber, BL
Citation: Lj. Pierce et al., Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations, J CL ONCOL, 18(19), 2000, pp. 3360-3369
Prophylactic surgery: Oophorectomy or adnexectomy? Reply
Authors: Eisen, A Rebbeck, TR Weber, BL Wood, WC
Citation: A. Eisen et al., Prophylactic surgery: Oophorectomy or adnexectomy? Reply, J CL ONCOL, 18(19), 2000, pp. 3455-3455
Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs
Authors: Dorval, M Patenaude, AF Schneider, KA Kieffer, SA DiGianni, L Kalkbrenner, KJ Bromberg, JI Basili, LA Calzone, K Stopfer, J Weber, BL Garber, JE
Citation: M. Dorval et al., Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs, J CL ONCOL, 18(10), 2000, pp. 2135-2142
Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families
Authors: Coyne, JC Benazon, NR Gaba, CG Calzone, K Weber, BL
Citation: Jc. Coyne et al., Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families, J CONS CLIN, 68(5), 2000, pp. 864-874
BRCA1 physically and functionally interacts with ATF1
Authors: Houvras, Y Benezra, M Zhang, HB Manfredi, JJ Weber, BL Licht, JD
Citation: Y. Houvras et al., BRCA1 physically and functionally interacts with ATF1, J BIOL CHEM, 275(46), 2000, pp. 36230-36237
Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing
Authors: Unger, MA Nathanson, KL Calzone, K Antin-Ozerkis, D Shih, HA Martin, AM Lenoir, GM Mazoyer, S Weber, BL
Citation: Ma. Unger et al., Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing, AM J HU GEN, 67(4), 2000, pp. 841-850
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 - Response
Authors: Amirimani, B Walker, AH Weber, BL Rebbeck, TR
Citation: B. Amirimani et al., Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 - Response, J NAT CANC, 91(18), 1999, pp. 1588-1590
Risultati: 1-25 | 26-35